1.Clinical review of surgical geratric patients over 65 years of age.
Jong Baek KIM ; Sung KIM ; Won Jin CHOI
Journal of the Korean Surgical Society 1992;42(4):537-546
No abstract available.
Humans
2.Clinical experience on split thickness skin graft from the scalp.
Jin Hwan KIM ; Rong Min BAEK ; Kab Sung OH ; Jun CHOE ; Se Min BAEK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1992;19(6):959-968
No abstract available.
Scalp*
;
Skin*
;
Transplants*
3.Refined correction method of unilateral cleft lip nasal deformity.
Yeon Chul JUNG ; jin Hwan KIM ; Rong Min BAEK ; Kab Sung OH ; Se Min BAEK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(5):1006-1013
No abstract available.
Cleft Lip*
;
Congenital Abnormalities*
4.Intraoperative Coagulation Management by TEG in a Patient with Aplastic Anemia: A case report.
Jin Eui BAEK ; Sang Bum KIM ; Ho Sung KWAK
Korean Journal of Anesthesiology 1997;33(4):757-761
This case was an acquired aplastic anemia patient who required a major operation for excision of a mediastinal mass. The authors previewed that the coagulation abnormalities would be developed due to major operation. Thus we decided to monitoring the coagulation function using the thromboelastography during the perioperative period and checked the complete blood count, concommitantly. The total blood volume lost during operation was 1800 ml, so we gave him a transfusion of 10 U's of platelet concentrate, 10 U's of pheretic platelet rich plasma and 5 U's of whole blood. The thromboelastography was a good guide that helped us to avoid excessive treatment of the coagulation abnormalities. We concluded that the thromboelastograhy was a reliable and effective monitoring system at the intraoperative coagulation management.
Anemia, Aplastic*
;
Anesthesia, General
;
Blood Cell Count
;
Blood Platelets
;
Blood Volume
;
Humans
;
Perioperative Period
;
Platelet-Rich Plasma
;
Thrombelastography
5.In vivo antitumor effects of lactic acid bacteria on sarcoma 180 and mouse lewis lung carcinoma.
Hyung Yong KIM ; Hyeong Suk BAE ; Young Jin BAEK
Journal of the Korean Cancer Association 1991;23(2):188-196
No abstract available.
Animals
;
Bacteria*
;
Carcinoma, Lewis Lung*
;
Lactic Acid*
;
Mice*
;
Sarcoma 180*
;
Sarcoma*
6.Consideration of Rescue Breathing methods during Infant Basic Life Support.
Bum Ju KIM ; Young Ho JIN ; Jae Baek LEE
Journal of the Korean Society of Emergency Medicine 2000;11(1):105-110
BACKGROUND: The current recommendation of rescue breathing techniques in the infant is to blow both the nose and mouth of infants by caregiver's mouth but recent studies suggest some caregivers may have trouble sealing a infant's mouth and nose. The purpose of this study is to estimate the ability of mothers to create a seal to their infants for the provision of rescue breathing according to current recommendation. METHODS: Infants up to 1 year of age(n=98) and their mothers were enrolled from emergency department of Chonbuk National University Hospital. We measured the facial lengths of the infants and the width of mouth in their mothers and compared mouth widths of mothers with their infant's nose-to-mouth lengths. RESULTS: In infants between 0 to 6 months, Mother transverse lengths were significantly larger than mouth, nose and nose-to-mouth lengths of the infants. In infants between 7 to 12 months, Mother transverse lengths were significantly larger than mouth and nose lengths of the infants but there was no statistically significant difference between mother transverse lengths and nose-to-mouth lengths of infants. CONCLUSION: The finding indicate that the present recommendation to cover mouth and nose is partly not possible. We recommend that the mouth-to-nose ventilation of rescue breathing techniques for the infants who have respiratory arrest be taught to mothers.
Caregivers
;
Emergency Service, Hospital
;
Humans
;
Infant*
;
Jeollabuk-do
;
Mothers
;
Mouth
;
Nose
;
Respiration*
;
Ventilation
7.Observation on 387 cases of peripheral cytopenia undergone bone marrow examination.
Jin Young BAEK ; Ki Sook HONG ; Ok Kyung KIM
Korean Journal of Hematology 1993;28(2):357-363
No abstract available.
Bone Marrow Examination*
;
Bone Marrow*
8.Comparison of clinical outcomes of anterior combined latissimus dorsi and teres major tendon transfer for anterior superior irreparable rotator cuff tear between young and elderly patients
Chang Hee BAEK ; Bo Taek KIM ; Jung Gon KIM ; Seung Jin KIM
Clinics in Shoulder and Elbow 2024;27(3):327-337
Background:
Anterior combined latissimus dorsi and teres major (aLDTM) tendon transfer has shown promise as a treatment for anterior superior irreparable rotator cuff tears (ASIRCTs). Our study aimed to compare aLDTM clinical outcomes for ASIRCTs between young and elderly patients.
Methods:
This retrospective study reviewed data from patients who underwent aLDTM tendon transfer for ASIRCTs with minimum 2-year follow-up. Clinical evaluations included visual analog scale (VAS), American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE), active range of motion (aROM), strength, and complications. Radiologic assessments included acromiohumeral distance, Hamada classification, and integrity of transferred tendon. Patients were divided into group total (all ages), group old (≥70 years), and group young (≤60 years).
Results:
A total of 123 patients were enrolled with 39 in group young (mean age, 56.6±4.9 years) and 27 in group old (mean age, 73.6±2.3 years). Postoperatively, both groups showed significant improvements in VAS, ASES, and SANE scores and improved aROM for forward elevation, abduction, and internal rotation. No significant differences in clinical coutcomes were noted between the groups. Furthermore, similar rates of complications, including retears and postoperative infections, were observed across all three groups.
Conclusions
Our study highlights the effectiveness of aLDTM transfer for ASIRCTs with minimal glenohumeral arthritis, demonstrating similar outcomes in both group young and group old patients. Moreover, patients in these distinct age groups showed comparable clinical results when compared to group total.Level of evidence: III.
9.Comparison of clinical outcomes of anterior combined latissimus dorsi and teres major tendon transfer for anterior superior irreparable rotator cuff tear between young and elderly patients
Chang Hee BAEK ; Bo Taek KIM ; Jung Gon KIM ; Seung Jin KIM
Clinics in Shoulder and Elbow 2024;27(3):327-337
Background:
Anterior combined latissimus dorsi and teres major (aLDTM) tendon transfer has shown promise as a treatment for anterior superior irreparable rotator cuff tears (ASIRCTs). Our study aimed to compare aLDTM clinical outcomes for ASIRCTs between young and elderly patients.
Methods:
This retrospective study reviewed data from patients who underwent aLDTM tendon transfer for ASIRCTs with minimum 2-year follow-up. Clinical evaluations included visual analog scale (VAS), American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE), active range of motion (aROM), strength, and complications. Radiologic assessments included acromiohumeral distance, Hamada classification, and integrity of transferred tendon. Patients were divided into group total (all ages), group old (≥70 years), and group young (≤60 years).
Results:
A total of 123 patients were enrolled with 39 in group young (mean age, 56.6±4.9 years) and 27 in group old (mean age, 73.6±2.3 years). Postoperatively, both groups showed significant improvements in VAS, ASES, and SANE scores and improved aROM for forward elevation, abduction, and internal rotation. No significant differences in clinical coutcomes were noted between the groups. Furthermore, similar rates of complications, including retears and postoperative infections, were observed across all three groups.
Conclusions
Our study highlights the effectiveness of aLDTM transfer for ASIRCTs with minimal glenohumeral arthritis, demonstrating similar outcomes in both group young and group old patients. Moreover, patients in these distinct age groups showed comparable clinical results when compared to group total.Level of evidence: III.
10.Comparison of clinical outcomes of anterior combined latissimus dorsi and teres major tendon transfer for anterior superior irreparable rotator cuff tear between young and elderly patients
Chang Hee BAEK ; Bo Taek KIM ; Jung Gon KIM ; Seung Jin KIM
Clinics in Shoulder and Elbow 2024;27(3):327-337
Background:
Anterior combined latissimus dorsi and teres major (aLDTM) tendon transfer has shown promise as a treatment for anterior superior irreparable rotator cuff tears (ASIRCTs). Our study aimed to compare aLDTM clinical outcomes for ASIRCTs between young and elderly patients.
Methods:
This retrospective study reviewed data from patients who underwent aLDTM tendon transfer for ASIRCTs with minimum 2-year follow-up. Clinical evaluations included visual analog scale (VAS), American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE), active range of motion (aROM), strength, and complications. Radiologic assessments included acromiohumeral distance, Hamada classification, and integrity of transferred tendon. Patients were divided into group total (all ages), group old (≥70 years), and group young (≤60 years).
Results:
A total of 123 patients were enrolled with 39 in group young (mean age, 56.6±4.9 years) and 27 in group old (mean age, 73.6±2.3 years). Postoperatively, both groups showed significant improvements in VAS, ASES, and SANE scores and improved aROM for forward elevation, abduction, and internal rotation. No significant differences in clinical coutcomes were noted between the groups. Furthermore, similar rates of complications, including retears and postoperative infections, were observed across all three groups.
Conclusions
Our study highlights the effectiveness of aLDTM transfer for ASIRCTs with minimal glenohumeral arthritis, demonstrating similar outcomes in both group young and group old patients. Moreover, patients in these distinct age groups showed comparable clinical results when compared to group total.Level of evidence: III.